Literature DB >> 21686894

Amiodarone induced acute interstitial pneumonitis.

Thanigaiarsu Thiyagarajan1, Vijay Mahajan, Srinivas Katragadda, Priya Kumaraguru.   

Abstract

Amiodarone has several potentially fatal toxicities, the most important of which is amiodarone pulmonary toxicity (APT). We report a rare case where a patient developed acute interstitial pneumonitis 2 days after starting amiodarone. This report reveals the potential for rapid onset of APT and will help to increase awareness among health care professionals who very often underestimate the incidence of the toxic effects of amiodarone. A simple, cost effective screening tool to detect APT in its early stage is recommended.

Entities:  

Year:  2009        PMID: 21686894      PMCID: PMC3027963          DOI: 10.1136/bcr.06.2008.0218

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Amiodarone.

Authors:  J W Mason
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

Review 2.  Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.

Authors:  B Coudert; F Bailly; J N Lombard; F Andre; P Camus
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

Review 3.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

Authors:  W J Martin; E C Rosenow
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

Review 4.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2).

Authors:  W J Martin; E C Rosenow
Journal:  Chest       Date:  1988-06       Impact factor: 9.410

5.  Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography.

Authors:  D L Wood; M J Osborn; J Rooke; D R Holmes
Journal:  Mayo Clin Proc       Date:  1985-09       Impact factor: 7.616

  5 in total
  1 in total

Review 1.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.